menu
    • menu

    Company profile for Alto Neuroscience

    NEW Drugs in Dev: 8
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    To bring every person suffering from a mental health condition the right treatment for them, right away. Alto Neuroscience is a clinical-stage biopharmaceutical company that integrates the biology of the patient into drug development to improve the lives of people with mental health conditions. Through our AI-enabled biomarker platform, we combine rich sources of information on patients’ brain activity and behavior to rapid...
    To bring every person suffering from a mental health condition the right treatment for them, right away. Alto Neuroscience is a clinical-stage biopharmaceutical company that integrates the biology of the patient into drug development to improve the lives of people with mental health conditions. Through our AI-enabled biomarker platform, we combine rich sources of information on patients’ brain activity and behavior to rapidly develop highly-effective medicines for targeted populations. We aim to replace today's trial-and-error clinical approach by aligning the right Alto drug with the right patient

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Alto NeuroscienceUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    369 South San Antonio Road Los Altos, CA 94022
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.altoneuroscience.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/altoneuroscience/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    International Sweetener Colloquium

    Not Confirmed

    envelop Contact Supplier

    International Sweetener Colloquium

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Alto Neuroscience Wraps Up Enrollment of ALTO-101 Phase 2 Study
    Alto Neuroscience Wraps Up Enrollment of ALTO-101 Phase 2 Study

    13 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260213343048/en/Alto-Neuroscience-Announces-Completion-of-Enrollment-in-Phase-2-Proof-of-Concept-Study-of-ALTO-101-in-Cognitive-Impairment-Associated-with-Schizophrenia

    BUSINESSWIRE
    13 Feb 2026
    Share Share
    Alto Neuroscience Secures Patent for ALTO-207 in Depression
    Alto Neuroscience Secures Patent for ALTO-207 in Depression

    14 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260114749833/en/Alto-Neuroscience-Strengthens-Intellectual-Property-Portfolio-with-Issuance-of-New-Method-of-Treatment-Patent-for-ALTO-207-in-Depression

    BUSINESSWIRE
    14 Jan 2026
    Share Share
    Alto Neuroscience Presents New Data at ACNP 2026 Meeting
    Alto Neuroscience Presents New Data at ACNP 2026 Meeting

    13 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260113754206/en/Alto-Neuroscience-Presents-New-Data-at-the-64th-Annual-Meeting-of-the-American-College-of-Neuropsychopharmacology

    BUSINESSWIRE
    13 Jan 2026
    Share Share
    Alto Neuroscience: New Inducement Stock Grants Under NYSE Rule
    Alto Neuroscience: New Inducement Stock Grants Under NYSE Rule

    03 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251203087055/en/Alto-Neuroscience-Announces-New-Employee-Inducement-Grants-Under-NYSE-Rule-303A.08

    BUSINESSWIRE
    03 Dec 2025
    Share Share
    Alto Neuroscience Reveals Q3 2025 Financials & Business Updates
    Alto Neuroscience Reveals Q3 2025 Financials & Business Updates

    12 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251112497891/en/Alto-Neuroscience-Reports-Third-Quarter-2025-Financial-Results-and-Recent-Business-Highlights

    BUSINESSWIRE
    12 Nov 2025
    Share Share
    Alto Neuroscience To Participate In Upcoming Investor Conferences
    Alto Neuroscience To Participate In Upcoming Investor Conferences

    28 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251028146760/en/Alto-Neuroscience-to-Participate-in-Upcoming-Investor-Conferences

    BUSINESSWIRE
    28 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search